Joby Aviation has agreed to buy Resonant Sciences for a base price of $500 million, creating an unusual pairing: a pre-commercial electric-aircraft developer will own an established defense contractor before its core air-taxi business has completed certification. The transaction is expected to use roughly $450 million of cash and $50 million of Joby shares and to close in the first half of 2027, subject to regulatory and national-security approvals. The Verge framed the move as a major expansion of Joby's military ambitions. The more useful investor question is whether Joby is buying a second operating clock that reduces risk, or adding another set of deadlines to a company already racing toward commercial launch.
The deal does add something Joby's air-taxi program does not yet have at scale: current customers, revenue, production activity and positive adjusted EBITDA. Yet those benefits do not automatically make the purchase self-funding. Joby is exchanging a meaningful part of its liquidity for a business whose most important contracts are partly shielded from public scrutiny. The investment case therefore rests less on the strategic vocabulary of autonomy and dual-use technology than on cash conversion, staff retention and management's ability to keep the certification program moving.
The purchase price buys earnings, but not transparency
Joby's announcement filed with the SEC says Resonant generated more than $100 million of revenue in the trailing 12 months, grew that revenue by about 40% year over year and recently operated at high-teens adjusted EBITDA margins. It also says first-half 2026 bookings were more than three times the comparable 2025 level and backlog more than doubled. Those figures support the idea that Joby is acquiring an operating platform rather than a research project. They are still management disclosures, however, not standalone audited accounts. The release does not quantify customer concentration, backlog duration, cancellation rights or cash conversion.
That disclosure gap matters because the purchase agreement summary sets a $500 million base price, adjustable for cash, debt, expenses and working capital. Approximately $50 million is expected to be paid in shares to management holders, with the rest in cash. The deal includes an outside date of February 8, 2027, subject to extensions for regulatory and national-security review. Investors can see the consideration and the conditions, but not enough contract-level economics to calculate a dependable valuation multiple.
There is a credible reason for opacity. Resonant says it has about 250 employees, more than 90% with security clearances, and supports classified programs through accredited facilities. Its equipment is qualified on more than 20 commercial and defense airframes. A cleared workforce, customer access and production infrastructure can be harder to reproduce than a patent portfolio. The counterargument to valuation skepticism is therefore strong: Joby may be paying for scarce institutional capability. Scarcity still needs to show up in durable margins and cash, not only in an impressive capability list.
$450 million of cash competes with certification capital
Joby reported $2.264 billion of cash, cash equivalents and short-term investments at June 30. The expected cash payment is about one-fifth of that total. This is affordable in an accounting sense, but the same second-quarter 10-Q shows why liquidity cannot be treated as surplus. The company used $317.6 million of cash in operations during the first half, spent $372.1 million on research and development and recorded a $355.4 million net loss. Second-quarter revenue was $38.6 million, of which $36.2 million came from passenger services, primarily the acquired Blade operation, rather than electric-air-taxi service.
Resonant's positive adjusted EBITDA can soften that profile, but its disclosed scale is small beside Joby's current investment rate. The acquisition is not a substitute for funding certification, manufacturing and launch. On the same date as the deal filing, Joby registered an at-the-market program allowing up to $750 million of common-stock sales. The facility is optional, not evidence that all those shares will be sold. It nevertheless makes the financing trade-off visible: cash used for Resonant may later be replenished with equity, which would shift part of the cost to dilution.
A separate defense unit protects focus only on paper
Upon closing, Resonant is meant to keep its name and leadership and become Joby's dedicated defense unit. Joby plans to move its existing defense initiatives into that business while leaving the commercial organization focused on air-taxi certification, manufacturing and service. This structure is sensible. Defense contracting, security controls and commercial aviation certification require different operating rhythms.
Legal separation does not eliminate integration. The strategic case depends on combining Joby's propulsion, hybrid-aircraft and autonomy work with Resonant's radio-frequency sensing, mission systems and low-observability expertise. That requires shared engineering priorities, intellectual-property controls and capital decisions. Classified work may limit how freely teams and investors can inspect progress. If Resonant merely remains a profitable subsidiary, the deal is diversification. If technology moves across the boundary and wins larger programs without delaying the commercial aircraft, it can become a genuine platform. Those are different outcomes and should not be valued as one.
Backlog conversion will decide whether diversification compounds
The decisive evidence will arrive after signing. First, the transaction must close without a material price adjustment or loss of key cleared staff. Next, Joby should disclose enough segment information to show how Resonant's backlog converts into revenue, adjusted EBITDA and operating cash. Margin expansion would be more persuasive if it survives purchase-accounting charges and integration costs. Finally, commercial milestones must continue: defense growth cannot compensate for a certification schedule that slips because attention or capital moved elsewhere.
The thesis would strengthen if Resonant produces repeatable cash, contract concentration remains manageable and Joby's air-taxi program advances on schedule without heavy use of the new equity facility. It would weaken if backlog growth fails to convert, margins compress after acquisition, or equity issuance becomes the practical funding source for both the deal and continuing development. Joby is not simply buying defense revenue. It is choosing to run two operating clocks, and shareholders need evidence that each can advance without borrowing time from the other.